Literature DB >> 31134566

Designing Cell-Permeable Macrocyclic Peptides.

George Appiah Kubi1, Patrick G Dougherty1, Dehua Pei2.   

Abstract

Peptides provide an attractive modality for targeting challenging drug targets such as intracellular protein-protein interactions. Unfortunately, peptides are generally impermeable to the cell membrane and inherently susceptible to proteolytic degradation in vivo. Macrocyclization of peptides greatly increases their proteolytic stability and in some cases the cell-penetrating activity. Conjugation of peptidyl cargoes to cyclic cell-penetrating peptides has resulted in potent, cell-permeable, and metabolically stable macrocyclic peptides against intracellular protein targets. Proper conjugation/integration of a peptidyl cargo with a cyclic cell-penetrating peptide is critical to retain the activity of each component and generate a biologically active macrocyclic peptide. This chapter describes the different conjugation strategies that have been developed (including endocyclic, bicyclic, and reversible cyclization methods) and the detailed protocols for their preparation.

Entities:  

Keywords:  Bicyclic peptides; Cyclic cell-penetrating peptides; Cyclic peptides; Protein-protein interaction; Reversible cyclization

Mesh:

Substances:

Year:  2019        PMID: 31134566      PMCID: PMC7277897          DOI: 10.1007/978-1-4939-9504-2_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  30 in total

Review 1.  The Current State of Peptide Drug Discovery: Back to the Future?

Authors:  Antoine Henninot; James C Collins; John M Nuss
Journal:  J Med Chem       Date:  2017-08-11       Impact factor: 7.446

Review 2.  Cell-penetrating peptides: 20 years later, where do we stand?

Authors:  Chérine Bechara; Sandrine Sagan
Journal:  FEBS Lett       Date:  2013-05-10       Impact factor: 4.124

Review 3.  Macrocycles as protein-protein interaction inhibitors.

Authors:  Patrick G Dougherty; Ziqing Qian; Dehua Pei
Journal:  Biochem J       Date:  2017-03-15       Impact factor: 3.857

4.  Enhancing the Cell Permeability and Metabolic Stability of Peptidyl Drugs by Reversible Bicyclization.

Authors:  Ziqing Qian; Curran A Rhodes; Lucas C McCroskey; Jin Wen; George Appiah-Kubi; David J Wang; Denis C Guttridge; Dehua Pei
Journal:  Angew Chem Int Ed Engl       Date:  2016-12-30       Impact factor: 15.336

5.  Cellular uptake of the tat protein from human immunodeficiency virus.

Authors:  A D Frankel; C O Pabo
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

6.  Cell-permeable bicyclic peptidyl inhibitors against T-cell protein tyrosine phosphatase from a combinatorial library.

Authors:  Hui Liao; Dehua Pei
Journal:  Org Biomol Chem       Date:  2017-11-22       Impact factor: 3.876

Review 7.  Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.

Authors:  Sonu Sundd Singh
Journal:  Curr Drug Metab       Date:  2006-02       Impact factor: 3.731

8.  Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy.

Authors:  Yong S Chang; Bradford Graves; Vincent Guerlavais; Christian Tovar; Kathryn Packman; Kwong-Him To; Karen A Olson; Kamala Kesavan; Pranoti Gangurde; Aditi Mukherjee; Theresa Baker; Krzysztof Darlak; Carl Elkin; Zoran Filipovic; Farooq Z Qureshi; Hongliang Cai; Pamela Berry; Eric Feyfant; Xiangguo E Shi; James Horstick; D Allen Annis; Anthony M Manning; Nader Fotouhi; Huw Nash; Lyubomir T Vassilev; Tomi K Sawyer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-14       Impact factor: 11.205

9.  Efficient delivery of cyclic peptides into mammalian cells with short sequence motifs.

Authors:  Ziqing Qian; Tao Liu; Yu-Yu Liu; Roger Briesewitz; Amy M Barrios; Sissy M Jhiang; Dehua Pei
Journal:  ACS Chem Biol       Date:  2012-11-12       Impact factor: 5.100

10.  Systematic Analysis of Drug Targets Confirms Expression in Disease-Relevant Tissues.

Authors:  Vinod Kumar; Philippe Sanseau; Daniel F Simola; Mark R Hurle; Pankaj Agarwal
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

View more
  2 in total

1.  Umpolung AlaB Reagents for the Synthesis of Non-Proteogenic Amino Acids, Peptides and Proteins.

Authors:  Feng Zhu; Eric Miller; Wyatt C Powell; Kelly Johnson; Alexander Beggs; Garrett E Evenson; Maciej A Walczak
Journal:  Angew Chem Int Ed Engl       Date:  2022-06-23       Impact factor: 16.823

Review 2.  Modulating Protein-Protein Interactions by Cyclic and Macrocyclic Peptides. Prominent Strategies and Examples.

Authors:  Rosario González-Muñiz; María Ángeles Bonache; María Jesús Pérez de Vega
Journal:  Molecules       Date:  2021-01-16       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.